Abstract Degeneration of the noradrenergic neurons has been reported in the brain of patients suffering from neurodegenerative diseases. However, their pathological characteristics during the neurodegenerative course and underlying mechanisms remain to be elucidated. In the present study, we used the neurotoxin camptothecin (CPT) to induce the DNA damage response in neuroblastoma SH-SY5Y cells, normal fibroblast cells, and primarily cultured locus coeruleus (LC) and raphe neurons to examine cellular responses and repair capabilities after neurotoxin exposure. To our knowledge, the present study is the first to show that noradrenergic SH-SY5Y cells are more sensitive to CPTinduced DNA damage and deficient in DNA repair, as compared to fibroblast cells. Furthermore, similar to SH-SY5Y cells, primarily cultured LC neurons are more sensitive to CPT-induced DNA damage and show a deficiency in repairing this damage. Moreover, while N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) exposure also results in DNA damage in cultured LC neurons, neither CPT nor DSP4 induce DNA damage in neuronal cultures from the raphe nuclei. Taken together, noradrenergic SH-SY5Y cells and LC neurons are sensitive to CPT-induced DNA damage and exhibit a repair deficiency, providing a mechanistic explanation for the pathological characteristics of LC degeneration when facing endogenous and environmental DNA-damaging insults in vivo.
Introduction
The locus coeruleus (LC), a small nucleus located in the pons, is the main source of brain norepinephrine (NE) especially for the hippocampus and forebrain (Maeda 2000) . The activity of LC neurons is considered to be involved in numerous important functions including response to stress, attention, emotion, motivation, decision making, learning, and memory (Usher et al. 1999) . It is reported that LC neuronal numbers decrease during normal aging (Mann 1983; ) and in aging-related diseases (Chan-Palay 1991a; German et al. 1992) . Damage and loss of LC noradrenergic neurons are accelerated in certain progressive neurodegenerative diseases, such as Alzheimer's Diseases (AD) Bondareff et al. 1987; German et al. 1992; Grudzien et al. 2007 ) and Parkinson's Diseases (PD) Arima and Akashi 1990; Chan-Palay 1991b; Forno 1996) , which are early pathological indicators of these diseases. The greater neuronal loss was observed in the LC (83 % loss in AD; 68 % loss in PD) compared with other subcortical nuclei (the nucleus basalis and substantia nigra pars compact) Zarow et al. 2003) , and correlated to a reduced level of NE in the brain (Adolfsson et al. 1979; Palmer and DeKosky 1993) . However, despite extensive studies of AD and PD, it remains unclear why degeneration of the LC neurons precedes those neurons observed in other subcortical nuclei in these diseases.
It was reported that aging-related diseases are mainly caused by accumulation of nuclear DNA (nDNA) damage in neurons due to in sufficient nDNA repair. In the brain there are a large number of non-proliferative neuronal cells, which are vulnerable to defective DNA repair. Deficiencies in repairing DNA damage usually lead to accumulation of DNA lesions; the latter might be considered as the cause of the neuropathology in several neurodegenerative disorders. Certain neurons with a high amount of nDNA damage, like Purkinje cells in the rodent brain, would be removed during physiological aging, while other neurons with less nDNA damage may persist in the brain (Brasnjevic et al. 2008) . The molecular and cellular mechanisms of the selective neuronal vulnerability during aging/degenerative diseases are currently not clear. Therefore, exploring the pathological characteristics of LC noradrenergic neuronal loss during the neurodegenerative process is important for elucidating the pathological mechanisms underlying AD and PD.
Camptothecin (CPT) is a cytotoxic quinoline alkaloid and a S-phase-specific anticancer agent which inhibits DNA enzyme topoisomerase I .Generally, administration of CPT produced irreversible DNA doublestrand breaks during DNA synthesis, suggesting that this agent should not have toxic effects on non-replicating cells, such as neurons. However, it was reported that CPT can lead to death of post-mitotic rat cortical neurons in vitro in a significantly dose-dependent manner (Morris and Geller 1996) . Additionally, neurotoxic activity of CPT was found in cultured cerebellar granule neurons, which inhibited both protein synthesis and the neuritic outgrowth (Uday Bhanu and Kondapi 2010). These observations indicate that CPT also exhibits significant toxicity toward neuronal cells in vitro.
Effects of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) on NE levels in the peripheral and central noradrenergic system were first reported several decades ago (Ross 1976) . In vivo DSP4 selectively damages noradrenergic projections originating from the LC by interacting with the NE reuptake system and depleting intracellular NE, finally inducing degeneration of noradrenergic terminals (Winkler 1976; Ransom et al. 1985; Dooley et al. 1987; Prieto and Giralt 2001) . Our previous study showed that DSP4 induces DNA damage response (DDR) in neuroblastoma SH-SY5Y cells in a time-and dose-dependent manner (Wang et al. 2014) . However, whether DSP4 can induce DDR in primary cultured neurons remains unclear. To date, there are limited studies about the effects of neurotoxins on primary cultured neurons, therefore, it is essential to conduct this experiment to elucidate their pathophysiologic characteristics.
DSP4 has been widely used as a supplement neurotoxin to construct AD or PD animal models for the appearance of noradrenergic dysfunction (Srinivasan and Schmidt 2004; Heneka et al. 2006; Kalinin et al. 2007; Thomas et al. 2007 ). As a DNA-damaging agent, CPT is also occasionally used to mimetic cell impairments in the in vitro cell model (Malagelada et al. 2006 , Liu et al. 2014 . However, the precise pathological nature of these toxic agents and the response of cells upon their exposure, especially for CPT, have not been fully investigated. We hypothesize that different cells may exhibit alternative responses to neuronal impairments induced by these neurotoxins, and that these differences may reflect their cellular repair rate, which may decide their vulnerability to cellular insults. In the present study, we exposed neuroblastoma SH-SY5Y cells, which are considered as a noradrenergic cell line (Presgraves et al. 2004) , and primary cultures from the rat LC and raphe nuclei to CPT or DSP4. DDR markers were measured. The results showed that the noradrenergic SH-SY5Y cells and the primary LC neuronal cultures are severely affected by these neurotoxins, reflecting an increased sensitivity to CPT-or DSP4-induced DNA damage, and a deficiency in DNA repair, as compared to fibroblast cell lines or primary cultures from the raphe nuclei.
Materials and Methods

Cell Culture and Drug Exposure
Cell lines: The human neuroblastoma cell line SH-SY5Y and human normal fibroblast cells (AG08498) were used in these experiments. SH-SY5Y cells were maintained in a 1:1 mix of RPMI 1640 and F12 media. Normal fibroblast cells were maintained in Dulbecco's modified Eagle's medium. Both cell lines were supplemented with 10 % heat-inactivated fetal bovine serum (FBS), penicillin (100 U/ml), and streptomycin (100 lg/ml) and grown at 37°C in humidified air containing 5 % CO 2 . Culture media and supplements were obtained from Gibco-Invitrogen (Carlsbad, CA, USA). Cells were seeded into 6-well or 100-mm plates. Drug exposures were started 24 h after each subculture. Only SH-SY5Y cells prior to passage 10 were used. Cell viability was determined by exclusion of trypan blue dye; cell viability was 90-95 % in the untreated cells.
Primary tissue cultures: Timed pregnant SpragueDawley rats at day 12-15 of gestation (ED 12-15; the day following nocturnal mating being considered as ED 1) were anesthetized with ketamine/xylazine (100 mg/10 mg/ kg. i.p.). After laparotomy and hysterectomy, the embryos were removed and their brains dissected under a stereomicroscope based on the published paper (Dunnett and Bjorklund 1992) . Mesencephalic tissue pieces containing the raphe nuclei or LC were collected in ice-cold Hank's balanced salt solution (HBSS, Gibco-Invitrogen, Carlsbad, CA, USA) and incubated for 15 min at 37°C in a 15-ml centrifuge tube containing 4.5 ml HBSS, 0.5 ml 0.25 % trypsin-EDTA, and 25 ll RQ1 DNase (0.1 mg/ml deoxyribonuclease). The trypsinization was stopped by the addition of 5 ml HBSS containing 1 mM of pyruvate, 10 mM HEPES, and 1 ml of FBS. Subsequently, the cells were dissociated by gentle trituration using a fire-polished Pasteur pipette. The suspension was centrifuged at 3,000 rpm for 5 min and the pellet was suspended in culture medium, which contains neurobasal medium (GibcoInvitrogen, Carlsbad, CA, USA) supplemented with serum free B-27 (Gibco-Invitrogen, Carlsbad, CA, USA), 0.5 mM glutamine, 25 lM glutamate, penicillin (100 U/ml), and streptomycin (100 lg/ml). The cells were counted before plating. 1X10 5 /ml cells were transferred into each well of 24-well plate coated with poly-L-lysine (Sigma, St Louis, MO, USA). At 4 day in vitro (DIV), the medium was replaced by fresh media without glutamate. Thereafter, half of the medium was changed every 3 days. Cells were used for drug treatment at 12 DIV. DSP4 (Sigma, St Louis, MO, USA) was dissolved in distilled water at 50 mM, then diluted with culture media and added to cells to a final concentration of 50 lM. CPT (Cat. No. C9911, Sigma, St Louis, MO, USA) was dissolved in dimethyl sulfoxide at 10 mM, then diluted with culture media and added to cells to a final concentration of 10 lM. The selection of the concentration of DSP4 was based on our previous data (Wang et al. 2014) .The concentration of CPT was based on published papers (Uday Bhanu and Kondapi 2010). The control group in each experiment was treated with vehicle which is the fresh medium in the case of DSP4, or fresh medium containing the same amount of dimethyl sulfoxide as in the case of CPT.
Western Blot Analysis
Whole cell extracts for Western blot analysis were prepared by lysing cells in ice-cold Nonidet P-40 (NP-40; Sigma, St Louis, MO, USA) buffer (0.5 % NP-40, 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM EDTA) for 30 min, after which nuclei and cell debris were removed by centrifugation at 12,000 rpm for 10 min at 4°C. An equal volume of 2X sodium dodecyl sulfate (SDS) gel-loading buffer then was added to the supernatant and the samples were denatured at 70°C for 5 min. Protein concentrations in cell extracts were quantified prior to addition of the loading buffer with the Micro BCA Protein Assay Kit (Thermo Science, Rockford, IL USA). Proteins (40 lg) were electrophoretically separated on a 10 or 15 % SDSpolyacrylamide gel and electro-blotted onto a nitrocellulose membrane (Amersham Life Sciences, Buckinghamshire, UK). For protein detection, the blots were, respectively, probed with anti-cH2AX antibody (1:1,000 dilution, Bethyl Laboratories, Inc., Montgomery TX USA), or an antibody specific for p53 tumor-suppressor protein phosphorylated on serine 15 (anti-p-p53 ser15 )(1:1,000 dilution, Cell Signaling Technology, Inc., Danvers, MA, USA). A horseradish peroxidase-conjugated anti-mouse or anti-rabbit antibody (1:5,000 dilution; Amersham Life Sciences, Buckinghamshire, UK) was used as the secondary antibody. The membranes then were subjected to enhanced chemiluminescence (ECL, Amersham Life Sciences, Buckinghamshire, UK) or super ECL (Sigma Chemical Co., St Louis, MO, USA) and autoradiography. To check for equal loading and transfer, the membranes were reprobed with a mouse IgG monoclonal anti-ß-actin antibody (1:5,000 dilution, Amersham Life Sciences, Buckinghamshire, UK).
Immunofluorescence Assay (IFA) 2 9 10 4 cells were grown on coverslips in 24-well plates and treated with CPT (10 lM, for 2 h) or DSP4 (50 lM, for 24 h), or vehicle. The cells were fixed with 4 % paraformaldehyde for 15 min and permeabilized with 0.2 % Triton X-100 in phosphate buffered saline (PBS) for 10 min. The coverslips then were blocked with 5 % goat serum in PBS for 1 h, and incubated overnight with primary antibodies (anti-cH2AX: 1:200 dilution, GeneTexInc., Irvine, CA, USA), and anti-p-p53 ser15 (1:400 dilution, Cell Signaling Technology, Inc., Danvers, MA, USA). After 3 9 10-min washes with PBS, the coverslips were incubated with the secondary antibodies [AlexaFluor Ò 488 Goat Anti-Rabbit IgG (H ? L); AlexaFluor Ò 568 Goat Anti-Mouse IgG (H ? L), EMD Millipore Corporation, Billerica, MA, USA] and diluted in PBS with 5 % goat serum. Coverslips were mounted onto microscopic slides using Fluoromount-G mounting medium (Invitrogen, Grand Island, NY, USA). Slides were viewed and Comet Assay SH-SY5Y cells were treated with 10 lM CPT for 2 h, and then CPT was washed out. Cells were allowed to recover from the CPT-induced damage for 24, 48, and 72 h. The neutral and alkaline comet assays were carried out using the Comet Assay System (Trevigen Inc., Gaithersburg, MD, USA) according to the manufacturer's instructions.
Fluorescence images were captured at 109 magnification. The overall cell shape resembles a comet with a circular head corresponding to the undamaged DNA and a tail of damaged DNA. The level of damage can be measured by length of the tail. At least 50 cells were assessed per treatment. In parallel with the comet assay, cell cultures with the same treatments were harvested for the protein analysis by Western blotting.
Statistics
All experimental data are presented in the text and graph as the mean ± SEM. The number of replicates is enumerated in the figure legends. The statistics were performed using GraphPad Prism 6 software (GraphPad Software, Inc., San Diego, CA, USA). Data were analyzed using one-way analysis of variance (ANOVA), which was followed by a post hoc Newman-Keuls test for planned comparisons.
Results
SH-SY5Y Cells are More Sensitive to CPT-Induced DNA Damage as Compared to Fibroblastic Cells
In this study, noradrenergic SH-SY5Y cells, which richly express the noradrenergic hall mark proteins NE transporter (NET) and dopamine b-hydroxylase (DBH), were used.
Normal human fibroblast cells which express neither NET nor DBH were used as non-adrenergic cells (Fig. 1) . First, to examine whether noradrenergic SH-SY5Y cells were sensitive to CPT-induced DNA damage, SH-SY5Y and fibroblast cells were exposed to 10 lM CPT for 15, 30, 60, 90, and 120 min. Western blotting and IFA analysis were performed to measure cH2AX and p-p53 positive cells identified by IFA at different CPT treatment times. As shown in Fig. 2c , the percentage of cH2AX-positive fibroblast cells was 14.7 % after 90 min exposure and 100 % after 120 min exposure (F 5,12 = 377.5, p \ 0.0001). In contrast, percentages of cH2AX-positive SH-SY5Y cells were about 1.3, 29.3, 51.2, 74.0, and 77.7 % after CPT -positive fibroblast cells was 37.9 % after 120 min exposure (Fig. 3c, F 5 ,12 = 45.47, p \ 0.0001). However, treated SH-SY5Y cells exhibited a significantly higher levels of p-p53 ser15 -positive cells with the percentage of 36.6, 47.2, and 49.5 % after 60, 90, and 120 min CPT treatment, respectively (Fig. 3d, F 5 ,12 = 1,816, p \ 0.0001). Western blot results show that although the effect of CPT on cH2AX and p-p53 ser15 levels at 120 min after exposure is similar in both cell lines, the levels of cH2AX (Fig. 4e, g,  F 5 ,12 = 83.02, p \ 0.0001) and p-p53 ser15 (Fig. 4f , h, F 5,18 = 168.5, p \ 0.0001) were dramatically increased after a 60 min CPT exposure in SH-SY5Y cells than those in fibroblast cells (Fig. 4a, c, F 5 ,18 = 78, p \ 0.0001; Fig. 4b, d , F 5,18 = 868.9, p \ 0.0001). These results In order to examine whether DNA damage caused by CPT in SH-SY5Y cells was resistant to repair, we treated SH-SY5Y and fibroblast cells with CPT (10 lM) for 2 h. Cells were then briefly washed with PBS and continued to grow in fresh medium in the absence of CPT for 24, 48, 72, and 96 h. In normal fibroblast cells, numbers of cH2AX foci and levels of p-p53 ser15 were significantly reduced within 24 h after removal of CPT (Fig. 5a, b) . However, in SH-SY5Y cells, the number of cH2AX-positive cells was gradually reduced over 72 h (Fig. 6a, c, F 5 ,12 = 453.9, p \ 0.0001). Unexpectedly, the number of cH2AX-positive SH-SY5Y cells dramatically decreased from 76.9 to 41.0 % within 24 h, but increased from 41.0 to 52.3 % from 24 to 48 h after removal of CPT. The level of p-p53 ser15 in SH-SY5Y nuclei decreased gradually over 72 h (Fig. 6b, d, (Fig. 7) .
To further explore the repair efficiency, CPT-treated cells were analyzed by neutral and alkaline comet assays. Interestingly, tails in fibroblast cells were detected under both neutral and alkaline conditions, suggesting that CPT induces both double-strand breaks (DSBs) and singlestrand breaks (SSBs) in fibroblast cells (Fig. 8a) . However, tails were only detected under alkaline condition in SH-SY5Y cells (Fig. 8b) , which indicated SSBs. Tails gradually shorted or disappeared over 72 h in SH-SY5Y cells, while they began to short and disappear at 24 h in normal fibroblast cells (Fig. 8a) . Thus, by demonstrating in the persistence of DNA strand breaks in SH-SY5Y cell, these comet assay data confirm that CPT-induced DDRs are different in both cell lines as indicated by the IFAs and Western blotting.
In sum, compared to fibroblast cells, CPT-treated SH-SY5Y cells exhibited a delay in reducing levels of the two DDR markers cH2AX and p-p53 ser15 . In addition, comet assays showed that CPT-induced DNA damage was persistent in SH-SY5Y cells. These data indicated that SH-SY5Y cells were deficient in repairing CPT-induced DNA damage.
CPT-Induced DDR in Cultured LC and Raphe Neurons
The above observations (Figs. 2, 3, 4 , 5, 6, 7, 8) demonstrate that noradrenergic SH-SY5Y cells were sensitive to CPT-induced DNA damage and exhibit a deficiency in repairing the damage, compared to fibroblast cells. In order Fig. 5 The IFA measurement for cH2AX foci or p-p53 ser15 -positive fibroblast cells after CPT wash-out. Cells were treated with CPT (10 lM) for 2 h, then CPT was washed away. Cells were allowed to recover in fresh prepared media without CPT for 24 (R24) or 48 (R48) h. After 2 h CPT treatment, significant cH2AX foci (a) were found in nuclei, and the level of p-p53 ser15 (b) was increased in nuclei. The numbers of cH2AX-or p-p53 ser15 -positive cells were reduced within 24 h after CPT wash-out. The images were taken with 960 magnification. Blue: DAPI; red: cH2AX; green: p-p53 ser15 . Con: control group treated with vehicle. R24 and R48 h: after CPT was washed away, cells continued to grow in media without CPT for 24 or 48 h. DAPI: 4 0 ,4-diamidino-2-phenylindole, a fluorescent dye that strongly binds to DNA as a nuclear counterstain (Color figure online) to confirm that SH-SY5Y cells can be used as an appropriate in vitro noradrenergic cell model for in vivo studies, primary neuronal cultures from the LC and raphe nuclei were similarly treated with neurotoxins. Primary neuronal cultures derived from rodents are widely used to study basic physiological properties of neurons, and represent a useful tool to study the potential neurotoxicity of chemicals. Using a primary cultures from animal tissues such as the LC and raphe nuclei would facilitate investigations of various properties of these noradrenergic and non-noradrenergic neurons under well-controlled conditions (Masuko et al. 1986 ). The LC is the main source of noradrenergic neurons in the brain, while the raphe nuclei are the key center for serotonin-expressing neurons. Thus, primarily cultured LC and raphe neurons were used to examine whether these neurons respond to DNA damage differently from each other. The LC and raphe tissues were separated from 15-to 18-day rat embryos, then cultured for 12 days. Since we did not get enough neurons to do Western blots, therefore in this study, only IFA was employed. The primary cultures were treated with CPT (10 lM) for 2 h. After brief washing, cells were allowed to recover in the media without CPT for another 24, 48, or 72 h. As shown in Fig. 9 , significant cH2AX foci were found in LC neurons after CPT treatment (F 4,11 = 558.3, p \ 0.0001). The number of cH2AX-positive cells was gradually reduced over 72 h after CPT wash-out. However, we could barely detect cH2AX foci in raphe neurons after CPT treatment (Fig. 10) . Therefore, the primarily cultured LC neurons are sensitive to CPT-induced DNA damage and are deficient in repair of this damage.
LC Neurons Accumulate DSP4-Induced DNA Damage
The earlier studies showed that effects of DSP4 were initially restricted to the nerve terminals originating from the LC (Fritschy et al. 1990 ). However, the subsequent reports demonstrated that there was loss of LC neuronal cell bodies after DSP4 treatment (Fritschy and Grzanna 1991) . Also, the selective effects of DSP4 on noradrenergic neurons are documented (Jonsson et al. 1981; Fischer et al. 1983; Hallman and Jonsson 1984; Howard et al. 1990 ). Our previous study showed that DSP4 could induce DDR in SH-SY5Y cells (Wang et al. 2014) . To test the effects of DSP4 on primarily cultured LC and raphe neurons, neuronal cultures were treated with DSP4 (50 lM) for 24 h, and IFA was performed. As shown in Fig. 11b , cH2AX foci were detected in DSP4-treated primarily cultured LC neurons after DSP4 treatment. However, no significant cH2AX foci were found in primarily cultured raphe neurons after DSP4 treatment (Fig. 11a) .
Discussion
In the present study, cH2AX and p-p53 ser15 were measured as the DDR markers to evaluate the response to DNA damage induced by CPT or DSP4, as well as the repair rate for the DNA damage. Our data showed that SH-SY5Y cells are sensitive to accumulate CPT-induced DNA damage (Figs. 2, 3, 4) and are deficient in repairing this damage (Figs. 5, 6, 7, 8) , compared to that in fibroblast cells. In order to correlate these in vitro findings with those in in vivo conditions, we used primary LC and raphe neuronal cultures; such cultures would facilitate the investigation of various properties of these noradrenergic and non-noradrenergic neurons under well-controlled conditions and mimic the in vivo conditions. Our data show that LC neurons are more sensitive to DNA damage induced by CPT or DSP4 than raphe neurons (Figs. 9, 10, 11 ). These pathological characteristics are consistent with the in vivo observations which demonstrate that degeneration of noradrenergic neurons may occur at an early stage in the brain of neurodegenerative disease patients (Bondareff et al. 1982; Bondareff et al. 1987; German et al. 1992; Weinshenker 2008) .
As a very earlier step in the cellular response to DNA damage, histone H2AX is phosphorylated at C-terminal serine residues (Ser136 and Ser139) (Rogakou et al. 1998 ). This phosphorylated H2AX, called cH2AX, and cH2AX foci can be detected within minutes after the induction of DNA damages (Kang et al. 2005 ). H2AX phosphorylation not only is a DDR, but also has an important role in the initiation of DNA repair (Downs et al. 2000) , including the recruitment of DNA repair or damage-signaling factors to the damage site, maintenance of the integrity of the DDR, and bringing the broken DNA ends closer Alt 2004, Thiriet and Hayes 2005) . Similarly, p53 tumor-suppressor protein, known as a classic ''gatekeeper'' of cellular fate, is activated in response to genotoxic stress-induced DNA damage (May and May 1999) , among which the phosphorylation of serine-15 in p53 is one of the key responses (Hammond et al. 2002) . p-p53 ser15 levels may rapidly increase several folds after DNA damage. Phosphorylated p53 has been linked to DNA repair processes, such as activation of DNA repair and stalling the cell cycle (Offer et al. 1999 , Okorokov 2003 , Ford 2005 . Therefore, the formation and disappearance of cH2AX and p-p53 ser15 can be used to represent a relative time process in CPTinduced DDR and repair.
The LC is important for regulating the amount of NE in the brain (Maeda 2000) . A deficiency of the noradrenergic function in the brain, originating largely from loss of cells in the LC, is an early pathological indicator in the progression of multiple neurodegenerative disorders including PD and AD (Marien et al. 2004 ). Also, aging-related cognitive decline is associated with an accumulation of nDNA damage in the neurons (Rutten et al. 2003 (Rutten et al. , 2007 ; this effect may be due to insufficient nDNA repair. Our data show that noradrenergic SH-SY5Y cells and primary LC neuronal cultures exhibit an enhance sensitivity to CPT treatment, which results in accumulation of DNA damage (Fig. 2, 3, 4) . This sensitivity to CPT could stem from a deficiency of DNA repair in noradrenergic SH-SY5Y cells and LC neurons. Generally, the repair of DNA damage is dependent upon functional repair systems (Hickson et al. 1990 ). For example, it has been reported that cells without some DNA repair genes or DNA repair enzymes are hypersensitive to CPT and cannot repair CPT-induced DSBs (Nitiss and Wang 1988, Chatterjee et al. 1989) . Therefore, noradrenergic SH-SY5Y cells and LC neurons may be relatively deficient in DNA repair and consequently sensitive to DNA damage produced by CPT. This explanation is consistent with our data that SH-SY5Y cells and LC neurons are deficient in repairing CPTinduced DNA damage (Figs. 5, 6, 7, 8, 9) .
Additionally, it was reported that oxidative stress-induced DNA damage can lead to cell cycle arrest (Migliore and Coppede 2002) . For example, human fibroblasts treated with H 2 O 2 undergo either cell cycle arrest or apoptosis. The majority of the apoptotic fibroblasts are in the S-phase, whereas growth-arrested cells were predominantly accumulated in the G1-or G2/M-phases (Chen et al. 2000) . This apoptotic death of fibroblasts in the S-phase is consistent with the death of neurons that have aberrant cell cycle activity and express the S-phase proteins. Hippocampal pyramidal and basal forebrain neurons from AD brains show chromosomal duplication but die before mitosis, which is consistent with cell death in the Sor G2-phase of the cell cycle (Nagy et al. 1997) . It was reported that insufficient nDNA repair leads to accumulation of nDNA damage in neurons. So if SH-SY5Y cells were in S-or G2/M-phases when CPT was added, these cells might have an enhanced response with much more cH2AX foci in damaged nuclei. This hypothesis may also explain our data in Fig. 6a . After a decrease in the number of cH2AX-positive cells at 24 h after CPT was washed away, they increased again at 48 h after removal of CPT. This effect may be explained as follows: at 24 h after removal of CPT, cells with significant of DNA damage died due to apoptosis, therefore the number of cH2AX-positive cells dramatically decreased. At 48 h after removal of CPT, the number of cH2AX-positive cells was less than unrecovered cells but higher than that at 24 h, indicating that cells with a lower amount of DNA damage recruited cH2AX to repair the damage, but this recruitment was at slower rate than in fibroblast cells. Further studies are needed to measure the viable cell number at each recovery time point and also to determine if cells with higher cH2AX levels are in any particular cell cycle phase, i.e., the S-or G2/M-phase. The generated data will help to explain why a dramatically decreased expression of cH2AX occurs at 24 h after wash-out CPT.
In Fig. 8 , under neutral conditions, CPT-induced DNA damage was detected as DSBs in fibroblast cells, but not in SH-SY5Y cells. This indicates that CPT does not induce DSBs in SH-SY5Y cells. However, CPT-induced DNA damage could be detected in both SH-SY5Y and fibroblast cells under alkaline condition, which suggests that CPT induces SSBs in both cell lines. CPT inhibits topoisomerase I after it has opened one DNA strand; the conversion of such SSBs into DSBs occurs during S-phase when the replication fork collides with the single-strand cleavage complexes formed on DNA by topoisomerase I-CPT complex. These data suggest that the CPT-induced SSBs in SH-SY5Y cells immediately arrest the cell cycle and/or replication in the S-phase cell, thus preventing the conversion of SSB to DSB.
CPT induces DNA DSBs during DNA synthesis (Sphase), suggesting that this agent should not be toxic to nondividing cells, such as neurons. However, CPT induces significant and dose-dependent cell death of post-mitotic rat cortical neurons and its neurotoxic activity also was found in cultured cerebellar granule neurons (Morris and Geller 1996, Uday Bhanu and Kondapi 2010) . Taken together, these observations indicate that CPT also exhibits significant toxicity toward neuronal cells in vitro. This could explain the results in Fig. 9 , in which CPT was observed to induce DDR in LC neurons. In the present study, exposure of the primary cultures from rat raphe nuclei to CPT (Fig. 10) or DSP4 (Fig. 11a) did not cause obvious DDR, indicating a potential neuronal selectivity of these neurotoxin actions. Although to date there is no report about effects of CPT on serotonergic neurons in vitro or in vivo, the result of DSP4 is in agreement with previous studies in that DSP4 did not change the amount of 5-hydroxytryptamine and its metabolite 5-hydroxyindoleacetic acid in the hippocampus (Jackisch et al. 2008 ) and dorsal raphe nucleus (Cassano et al. 2009 ). Also, previous studies have demonstrated that DSP4 treatment of Fischer 344 rats affects only noradrenergic neurons, leaving serotonergic and dopaminergic neurons intact (Chrobak et al. 1985, Martin and Elgin 1988) . However, it was reported that DSP4 could induce a decrease of 5-HT concentrations in the cerebral cortex, mesencephalon, and spinal cord (Fornai et al. 1996 , Jackisch et al. 2008 . Further studies are warranted to clarify their selectivity on different neurons, especially in vivo.
In summary, in the present study, SH-SY5Y cells and primary cultures from rat LC are more sensitive to neurotoxins CPT-or DSP4-induced DNA damage, and deficient in repairing the damage, compared to fibroblast cells and raphe neurons, respectively. It can be concluded that the more sensitivity to neurotoxins and deficiency in repair capacity in noradrenergic neurons may account for their vulnerability after cellular insults. These pathological characteristics may be consistent with the in vivo observation that degeneration of noradrenergic neurons occurs earlier than other neuronal systems in the brain of neurodegenerative diseases. The present study may serve as an initial effort to explore the molecular mechanisms underlying pathophysiological alterations of LC neurons in PD and AD.
